Presentation TCT 2025 TCT 68: Early Initiation of PCSK9 Inhibitors in Acute STEMI: Safety and Efficacy Outcomes from the EARLY-STEMI Trial Presenter: Mohammed Ali October 28, 2025
Presentation TCT 2022 Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond Presenter: Marc Bonaca September 17, 2022
Presentation TCT 2021 Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond Presenter: Connie Hess November 06, 2021
Presentation TCT 2017 Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors Presenter: Gregg W. Stone, Peter H. Stone, Evan A. Stein November 01, 2017
Presentation TCT 2016 Hot Topic #3: Anti-ischemic Therapy: Beta Blockers, ACE Inhibitors, and Ranolazine - Are They Effective? Presenter: Bernard J. Gersh, Felix Mahfoud, Ori Ben-Yehuda November 01, 2016
Presentation TCT 2015 Hyperlipidemic Therapy: From Statins to PCSK9 Inhibitors Presenter: George D. Dangas, Paul A. Gurbel, Joshua W. Knowles October 13, 2015
Presentation TCT 2015 Optimal Medical Therapy After PCI: What Is Optimal, and What Is Realistic? Presenter: Bernard J. Gersh, Stephen D. Wiviott, David J. Maron October 13, 2015